Loss of p16INK4A stimulates aberrant mitochondrial biogenesis through a CDK4/Rb-independent pathway

Ethika Tyagi1, Bin Liu1, Chelsea Li1

  • 1The Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake, Utah, USA.

Oncotarget
|September 17, 2017
PubMed

Insights

The tumor suppressor p16INK4A (p16) regulates mitochondrial function and biogenesis independently of cell cycle control. Loss of p16 enhances mitochondrial superoxide production and cell migration.

Area of Science:

  • Cell Biology
  • Mitochondrial Biology
  • Cancer Research

Background:

  • The tumor suppressor p16INK4A (p16) is known to inhibit cell cycle progression via the CDK4/Rb pathway.
  • Previous research indicated p16's role in regulating cellular oxidative stress, independent of cell cycle control.

Purpose of the Study:

  • To investigate the direct impact of p16 loss on mitochondrial function and biogenesis.
  • To determine if p16's effects on mitochondria are linked to the CDK4/Rb pathway.

Main Methods:

  • Comparison of mitochondrial mass, respiratory protein expression, and transcription factor levels (PRC, TFAM) in p16-null and wild-type mouse fibroblasts.
  • Assessment of mitochondrial respiration capacity and morphology using electron microscopy.
  • Measurement of mitochondrial superoxide production and membrane potential.
  • Evaluation of cell migration in response to ROS scavengers and p16 expression levels.
  • Analysis of p16's effects in human melanocytes and melanoma cells, including experiments with CDK4 inhibition.

Main Results:

  • p16-null fibroblasts exhibited increased mitochondrial mass, respiratory protein expression, and elevated PRC/TFAM levels.
  • Reduced mitochondrial respiration capacity and abnormal mitochondrial morphology were observed in p16-deficient cells.
  • p16-deficient cells showed increased mitochondrial superoxide production and enhanced migration, which was ROS-dependent and required mitochondrial membrane potential.
  • Restoration of p16 expression normalized mitochondrial function and reduced cell migration.
  • Overexpression of p16 in human cells decreased mitochondrial respiratory proteins, enhanced respiration, and reduced migration.
  • CDK4 inhibition did not replicate the effects of p16 loss on mitochondria or migration.

Conclusions:

  • p16 directly regulates mitochondrial biogenesis and function.
  • These regulatory effects of p16 on mitochondria are independent of its canonical role in the CDK4/Rb pathway.
  • p16 influences cellular processes like migration through its impact on mitochondrial oxidative stress and function.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K